Akebia Therapeutics, Inc. SEC filings AKBA
Akebia Therapeutics, Inc. has 886 filings in SEC EDGAR's recent list, going back to Apr 8, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 23, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 14, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 6, 2026 |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 30, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Apr 28, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 3, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2026 | Mar 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 4, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Jan 26, 2026 |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Jan 30, 2026 | Jan 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 1, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 17, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 28, 2025 | Oct 28, 2025 |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 144 | Notice of proposed sale | Jun 30, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 29, 2025 | Apr 29, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Mar 20, 2025 | Mar 19, 2025 |
| 424B5 | Prospectus supplement | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Mar 19, 2025 | — |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 7, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| S-8 | Employee stock plan registration | Jan 30, 2025 | — |
| 4 | Insider transaction | Jan 22, 2025 | Jan 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2024 | Oct 22, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 16, 2024 | Oct 15, 2024 |
| EFFECT | Filing | Sep 12, 2024 | — |
| CORRESP | Letter to the SEC | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2024 | — |
| S-3 | Shelf registration | Sep 3, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jul 11, 2024 | Jul 10, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 3 | Initial insider ownership | Jun 26, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 24, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 13, 2024 |
| 144 | Notice of proposed sale | May 13, 2024 | — |
| 144 | Notice of proposed sale | May 13, 2024 | — |
| 4 | Insider transaction | May 9, 2024 | Aug 25, 2023 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Apr 25, 2024 |
| 8-K |
Current report
New debt
|
Apr 23, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 16, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 28, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2024 | Mar 15, 2024 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 144 | Notice of proposed sale | Feb 29, 2024 | — |
| 144 | Notice of proposed sale | Feb 29, 2024 | — |
| 144 | Notice of proposed sale | Feb 29, 2024 | — |
| 144 | Notice of proposed sale | Feb 29, 2024 | — |
| 144 | Notice of proposed sale | Feb 27, 2024 | — |
| 144 | Notice of proposed sale | Feb 27, 2024 | — |
| 144 | Notice of proposed sale | Feb 27, 2024 | — |
| 144 | Notice of proposed sale | Feb 27, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2024 | Feb 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 144 | Notice of proposed sale | Feb 1, 2024 | — |
| 144 | Notice of proposed sale | Feb 1, 2024 | — |
| S-8 | Employee stock plan registration | Jan 30, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Jan 30, 2024 | Jan 29, 2024 |
| 3 | Initial insider ownership | Jan 18, 2024 | Jan 8, 2024 |
| 3 | Initial insider ownership | Jan 18, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 18, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 21, 2023 | Nov 21, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 2, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2023 | Oct 25, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2023 | Oct 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2023 | Sep 26, 2023 |
| 10-Q | Quarterly report | Aug 28, 2023 | Jun 30, 2023 |
| 10-K/A | Amended annual report | Aug 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 25, 2023 | Aug 25, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 17, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2023 | Aug 10, 2023 |
| NT 10-Q | Filing | Aug 10, 2023 | Aug 10, 2023 |
| 4 | Insider transaction | Aug 1, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2023 | Jul 26, 2023 |
| 3 | Initial insider ownership | Jul 18, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 18, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AKBA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1517022
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.